Primary care physicians who are on the payrolls of hospitals and health systems enjoy well-supported practice infrastructure and robust peer engagement. But they’re sometimes vexed by red tape and style-cramping oversight. Meanwhile independent PCPs … 

A poll of parents shows a distressingly large portion of this demographic is at a loss when it comes to scheduling appointments, figuring out whether or not they need medical care and navigating the healthcare system. 

The nonprofit Intermountain Health would take full ownership of Idaho Falls Community Hospital, and expand its minority share in physician-owned Mountain View Hospital, if the deal with Surgery Partners goes through.

The agency announced its appeal of a court ruling it lost to Clover Health, which resulted in the agency recalculating the grades it gave to the payer’s Medicare Part C plans. Other insurers are now asking for the same redo, spurring CMS to appeal the initial ruling.

Users of the popular online betting marketplace can now wager on specific FDA regulatory scenarios, including when Eli Lilly’s new weight loss drug will be approved, or when camizestrant will be given the greenlight to treat breast cancer.

In theory, GLP-1 receptor agonist drugs like semaglutide and tirzepatide should save a lot of money for the health insurers that pay for them. As it turns out, the lived reality is not keeping pace with the idealistic expectation. 

That equates to $16.25 per share, a 6% premium over the current market price. The deal will expand Tempus’ molecular residual disease test offerings, allowing the company to better support cancer patients.

All six counts of the company’s complaint were dismissed. The lawsuit stems from a May 2025 report from the outlet, where it was alleged the insurer paid incentive payments to nursing homes to reduce hospital transfers.